Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2023-12-07 Governance Information
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
董事会专门委员会议事规则（2023年第一次修订）
Governance Information Classification · 95% confidence The document is titled "董事会专门委员会议事规则（2023 年第一次修订）" which translates to "Board Special Committee Meeting Rules (First Revision in 2023)". It details the rules, composition, responsibilities, and procedures of the company's board committees such as the audit committee, nomination committee, remuneration committee, and strategic committee. The content is about governance structure and internal board rules rather than financial results, audit reports, or announcements. There is no indication of financial data, voting results, or report publication. The document is a governance-related internal rules update approved by the board. Therefore, it fits best under Governance Information (CGR). The document length is 4338 characters, which is sufficient for a detailed governance document, not a brief announcement. Hence, the classification is CGR with high confidence.
2023-12-07 Chinese
关于召开2023年第十一次临时股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice for the convening of the 11th extraordinary general meeting of shareholders in 2023 for Beijing Kangle Weishi Biotechnology Co., Ltd. It includes details about the meeting date, voting methods (including online voting), agenda items such as amendments to the company charter and governance-related systems, and the proposal to reappoint the auditing firm. The document also provides instructions for shareholder registration and proxy voting. There are no financial statements or detailed financial data presented, nor is this a transcript or report of the meeting results. The document is a formal announcement and invitation to shareholders to attend and vote at the meeting, which fits the definition of AGM Information (AGM-R). The document length is under 5,000 characters and it is not an announcement of a report publication but the meeting notice itself.
2023-12-07 Chinese
独立董事工作制度（2023年第一次修订）
Governance Information Classification · 95% confidence The document is titled "独立董事工作制度（2023 年第一次修订）" which translates to "Independent Director Work System (2023 First Revision)". It is a detailed governance document outlining the roles, responsibilities, qualifications, appointment, and working conditions of independent directors at the company. It references relevant laws, regulations, and stock exchange rules, and includes procedural and governance details. There is no financial data, earnings information, or audit content. The document is a governance framework or internal rules document rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length (9738 characters) supports it being a full governance document rather than a brief announcement or notice.
2023-12-07 Chinese
拟续聘会计师事务所公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (Ernst & Young Hua Ming) as the auditor for the company for the 2023 fiscal year. It details the auditor's background, integrity, independence, and audit fees, as well as the board and audit committee's approval of the proposal. There are no actual financial statements or audit reports included, nor is this a full annual report or audit report. The document is a formal announcement related to audit services, not the audit report itself. Given the content and length (2644 characters), it fits best as a Regulatory Filing (RNS) because it is an official disclosure about auditor appointment but does not contain the audit report or financial data itself.
2023-12-07 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel at Beijing Kangle Weishi Biotechnology Co., Ltd. It details the names, positions, appointment dates, qualifications, and the impact of these appointments on the company. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the appointment notice. The content clearly fits the category of Board/Management Information, as it announces changes in senior management positions.
2023-12-07 Chinese
关联交易管理制度（2023年第一次修订）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度（2023 年第一次修订）' which translates to 'Related Party Transaction Management System (2023 First Revision)'. It is a detailed policy document outlining the rules, definitions, and procedures for managing related party transactions within the company. It includes sections on definitions of related parties, decision-making procedures, disclosure requirements, and voting rules related to related party transactions. The document is issued by the company's board and dated December 8, 2023. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under governance information. The document length is 5595 characters, which is substantive and contains the full policy text, not just an announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2023-12-07 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.